Ignite Creation Date:
2024-05-06 @ 2:06 AM
Last Modification Date:
2024-10-26 @ 11:13 AM
Study NCT ID:
NCT01964495
Status:
COMPLETED
Last Update Posted:
2022-04-05
First Post:
2013-09-30
Brief Title:
Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes REDUCE Study
Sponsor:
Medical Center Alkmaar
Organization:
Medical Center Alkmaar
Study Overview
Official Title:
Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes REDUCE Study
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REDUCE
Brief Summary:
The purpose of this study is to evaluate two different treatment strategies in patients admitted to hospital with Community Acquired Pneumonia The investigators hypothesize treatment according to both procalcitonin PCT and C-reactive protein CRP will be effective in reducing the length of antibiotic treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None